(Q36440905)

14 August 2017

title

Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease (English)

1 reference

14 August 2017

1 reference

James M Hollands

1

1 reference

14 August 2017

Edward F Foote

2

1 reference

14 August 2017

Alfonso Rodriguez

3

1 reference

14 August 2017

John Rothschild

4

1 reference

14 August 2017

Steven Young

5

1 reference

14 August 2017

publication date

1 April 2006

1 reference

American Journal of Health-System Pharmacy

14 August 2017

published in

1 reference

14 August 2017

volume

63

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

731-734

1 reference

Intravenous iron sucrose: establishing a safe dose

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

High dose intravenous iron: a note of caution

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050173

31 March 2020

Identifiers

DOI

10.2146/AJHP050173

1 reference

14 August 2017

1 reference